Abdulkareem, N. M., Jiang, Y., Qi, Y., Liu, X., Zhang, X., Cai, S., Shao, J., Jeter-Jones, S., Rinkenbaugh, A. L., Cheng, C., Hancock, F., Schwartz, J., Litton, J. K., Chang, J. T., Piwnica-Worms, H. (2026). Resistance to neoadjuvant talazoparib in triple-negative breast cancer by BRN2-induced ATR/STAT3 pathways or SHLD2 subclone expansion. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2513742123